koselugo
astrazeneca ab - selumetinib sulfate - neurofibromatosis 1 - agenti antineoplastici - koselugo as monotherapy is indicated for the treatment of symptomatic, inoperable plexiform neurofibromas (pn) in paediatric patients with neurofibromatosis type 1 (nf1) aged 3 years and above.
kos rodiola sinergico gocce integratore alimentare 100ml
kos srl -
kos partenio estratto secco integratore alimentare 60 compresse
kos srl -
kos olio di borragine integratore alimentare 30 perle
kos srl -
kos boswellia integratore estratto secco 60x450g
kos srl -
kos teanina integratore alimentare 60 compresse
kos srl -
kos egcg the verde integratore alimentare 30 capsule
kos srl -